turoctocog alfa
NN7008-4304
Approved small_molecule completed
Quick answer
turoctocog alfa for Congenital Bleeding Disorder is a Approved program (small_molecule) at Novo Nordisk A/S with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Congenital Bleeding Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed